top of page


GPCR Functional ‘Volume Control’ in Cell Systems

Is it your compound, or your assay?
The same GPCR ligand can behave like a full agonist, a partial agonist or show no agonism at all, depending on receptor density and assay sensitivity. This 16-page Eurofins DiscoverX white paper shows how to use that ‘volume control’ to reveal a compound’s true profile.
​
Inside the white paper:
âž” How receptor density shapes what you measure
âž” Inducible cell lines for receptor density modulation
âž” Hidden efficacy, inverse agonism and PAM-agonism
âž” Models that predict compound effects in vivo
bottom of page
